Jane Street Group, LLC Arrowhead Pharmaceuticals, Inc. Call Options Transaction History

Jane Street Group, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$39.62 - $69.97 $3.28 Million - $5.79 Million	-82,700 Reduced 72.61%	31,200 $1.44 Million
Q4 2021 Feb 15, 2022	BUY	$58.09 - $82.51 $1.68 Million - $2.38 Million	28,900 Added 34.0%	113,900 $7.55 Million
Q3 2021 Nov 16, 2021	SELL	$58.38 - $84.96 $1.61 Million - $2.34 Million	-27,600 Reduced 24.51%	85,000 $5.31 Million
Q2 2021 Aug 16, 2021	SELL	$62.15 - $90.32 $1.7 Million - $2.47 Million	-27,400 Reduced 19.57%	112,600 $9.33 Million
Q1 2021 May 18, 2021	SELL	$61.35 - $90.47 $3.89 Million - $5.74 Million	-63,400 Reduced 31.17%	140,000 $9.28 Million
Q4 2020 Feb 17, 2021	BUY	$43.82 - $85.37 $5.52 Million - $10.7 Million	125,900 Added 162.45%	203,400 $15.6 Million
Q3 2020 Nov 17, 2020	SELL	$33.21 - $51.27 $4.08 Million - $6.3 Million	-122,800 Reduced 61.31%	77,500 $3.34 Million
Q2 2020 Aug 17, 2020	BUY	$26.12 - $43.27 $3.83 Million - $6.35 Million	146,800 Added 274.39%	200,300 $8.65 Million
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $618,856 - $1.9 Million	-30,100 Reduced 36.0%	53,500 $1.54 Million
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $2.35 Million - $6.1 Million	83,600 New	83,600 $5.3 Million
Q3 2018 Nov 14, 2018	SELL	$14.0 - $20.3 $231,000 - $334,950	-16,500 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$6.37 - $14.02 $105,105 - $231,330	16,500 New	16,500 $224,000

295

92.3M

1.33M

549K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.99B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.